Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-12-16
1979-03-27
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
A61K 3700
Patent
active
041466136
ABSTRACT:
There is provided an anti-diabetic drug to be taken orally. This drug comprises a sulfonyl urea and a kinin in retarded form. The kinin may be a Brady kinin or kallidin and is used in retarded form in an amount of from about 10.mu. grams to about 20 milligrams per unit dosage.
REFERENCES:
"Arzneimittel", vol. I, Pharmakodynamica, Velag Chemie 1968, pp. 896-908.
"Diabetologie in Klinik und Praxis", (G. Thieme, Stuttgart (1974) pp. 18-23.
Frey, et al., "Klinische Wochenschrift" 1932, pp. 846-849.
Elmer et al., "Klinische Wochenschrift," 1932, pp. 1993-1995.
Dietze Gunther
Wicklmayr Matthias
Phillips Delbert R.
Thera Gesellschaft fur Patentverwertung mbH
LandOfFree
Oral anti-diabetic drug composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral anti-diabetic drug composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral anti-diabetic drug composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1821899